This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Koch, C. A. Articles by Chrousos, G. P. Search for Related Content PubMed PubMed Citation Articles by Koch, C. A. Articles by Chrousos, G. P.

The Molecular Pathogenesis of Hereditary and Sporadic Adrenocortical and Adrenomedullary Tumors

Pediatric and Reproductive Endocrinology Branch, National Institute of Child Health and Human Development, National Institutes of Health (C.A.K., K.P., G.P.C.), Bethesda, Maryland 20892; and Department of Medicine III, University of Leipzig (C.A.K.), 04103 Leipzig, Germany

Address all correspondence and requests for reprints to: Christian A. Koch, M.D., FACP, Department of Medicine III, University of Leipzig, Phil.-Rosenthalstrasse 27, 04103 Leipzig, Germany. E-mail: kochc{at}exchange.nih.gov.

Abstract

Modern imaging modalities lead to frequent detection of adrenal masses, most of them incidental findings. Although the majority of adrenocortical and adrenomedullary tumors are benign, there are no reliable clinical and laboratory markers to distinguish most of them from malignant neoplasms. The molecular mechanisms underlying the pathogenesis of these tumors have recently begun to be unraveled. A fruitful avenue for the elucidation of tumorigenesis has been the study of adrenal tumors that are manifestations of hereditary or postzygotic genetic syndromes, because one knows the "first hit", i.e. the primary gene defect. In contrast, in sporadic adrenal tumors the first hit, possibly a somatic mutation of a tumor-related gene, is unknown, and therefore the sequence of genetic alterations is difficult to establish. In this article we review in addition to our own work the literature on molecular aspects of adrenocortical and adrenomedullary tumorigenesis.

This article has been cited by other articles:

				A. Karagiannis, D. P Mikhailidis, V. G Athyros, and F. Harsoulis Pheochromocytoma: an update on genetics and management Endocr. Relat. Cancer, December 1, 2007; 14(4): 935 - 956. [Abstract] [Full Text] [PDF]

				M. Doghman, T. Karpova, G. A. Rodrigues, M. Arhatte, J. De Moura, L. R. Cavalli, V. Virolle, P. Barbry, G. P. Zambetti, B. C. Figueiredo, et al. Increased Steroidogenic Factor-1 Dosage Triggers Adrenocortical Cell Proliferation and Cancer Mol. Endocrinol., December 1, 2007; 21(12): 2968 - 2987. [Abstract] [Full Text] [PDF]

				E. Thouennon, A. G. Elkahloun, J. Guillemot, A.-P. Gimenez-Roqueplo, J. Bertherat, A. Pierre, H. Ghzili, L. Grumolato, M. Muresan, M. Klein, et al. Identification of Potential Gene Markers and Insights into the Pathophysiology of Pheochromocytoma Malignancy J. Clin. Endocrinol. Metab., December 1, 2007; 92(12): 4865 - 4872. [Abstract] [Full Text] [PDF]

				B. Bausch, W. Borozdin, V. F. Mautner, M. M. Hoffmann, D. Boehm, M. Robledo, A. Cascon, T. Harenberg, F. Schiavi, C. Pawlu, et al. Germline NF1 Mutational Spectra and Loss-of-Heterozygosity Analyses in Patients with Pheochromocytoma and Neurofibromatosis Type 1 J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2784 - 2792. [Abstract] [Full Text] [PDF]

				B. Bausch, A.-C. Koschker, M. Fassnacht, J. Stoevesandt, M. M. Hoffmann, C. Eng, B. Allolio, and H. P. H. Neumann Comprehensive Mutation Scanning of NF1 in Apparently Sporadic Cases of Pheochromocytoma J. Clin. Endocrinol. Metab., September 1, 2006; 91(9): 3478 - 3481. [Abstract] [Full Text] [PDF]

				G. OPOCHER, F. SCHIAVI, M. IACOBONE, A. TONIATO, S. SATTAROVA, Z. ERLIC, M. MARTELLA, C. MIAN, I. MERANTE BOSCHIN, L. ZAMBONIN, et al. Familial nonsyndromic pheochromocytoma. Ann. N.Y. Acad. Sci., August 1, 2006; 1073: 149 - 155. [Abstract] [Full Text] [PDF]

				J. Majnik, A. Patocs, K. Balogh, M. Toth, P. Gergics, A. Szappanos, A. Mondok, G. Borgulya, P. Panczel, Z. Prohaszka, et al. Overrepresentation of the N363S Variant of the Glucocorticoid Receptor Gene in Patients with Bilateral Adrenal Incidentalomas J. Clin. Endocrinol. Metab., July 1, 2006; 91(7): 2796 - 2799. [Abstract] [Full Text] [PDF]

				B. Allolio and M. Fassnacht Adrenocortical Carcinoma: Clinical Update J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 2027 - 2037. [Abstract] [Full Text] [PDF]

				A. Blanes, J. J. Sanchez-Carrillo, and S. J. Diaz-Cano Topographic Molecular Profile of Pheochromocytomas: Role of Somatic Down-Regulation of Mismatch Repair J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 1150 - 1158. [Abstract] [Full Text] [PDF]

				M. Bielinska, S. Kiiveri, H. Parviainen, S. Mannisto, M. Heikinheimo, and D. B. Wilson Gonadectomy-induced Adrenocortical Neoplasia in the Domestic Ferret (Mustela putorius furo) and Laboratory Mouse. Vet. Pathol., February 1, 2006; 43(2): 97 - 117. [Abstract] [Full Text] [PDF]

				L. S. Kirschner Emerging Treatment Strategies for Adrenocortical Carcinoma: A New Hope J. Clin. Endocrinol. Metab., January 1, 2006; 91(1): 14 - 21. [Abstract] [Full Text] [PDF]

				R Nawar and D Aron Adrenal incidentalomas -- a continuing management dilemma Endocr. Relat. Cancer, September 1, 2005; 12(3): 585 - 598. [Abstract] [Full Text] [PDF]

				S. J. Marx and W. F. Simonds Hereditary Hormone Excess: Genes, Molecular Pathways, and Syndromes Endocr. Rev., August 1, 2005; 26(5): 615 - 661. [Abstract] [Full Text] [PDF]

				M. Fassnacht, D. Weismann, S. Ebert, P. Adam, M. Zink, F. Beuschlein, S. Hahner, and B. Allolio AKT Is Highly Phosphorylated in Pheochromocytomas But Not in Benign Adrenocortical Tumors J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 4366 - 4370. [Abstract] [Full Text] [PDF]

				F. de Fraipont, M. El Atifi, N. Cherradi, G. Le Moigne, G. Defaye, R. Houlgatte, J. Bertherat, X. Bertagna, P.-F. Plouin, E. Baudin, et al. Gene Expression Profiling of Human Adrenocortical Tumors Using Complementary Deoxyribonucleic Acid Microarrays Identifies Several Candidate Genes as Markers of Malignancy J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1819 - 1829. [Abstract] [Full Text] [PDF]

				P. Luciani, P. Ferruzzi, G. Arnaldi, C. Crescioli, S. Benvenuti, G. Nesi, A. Valeri, I. Greeve, M. Serio, M. Mannelli, et al. Expression of the Novel Adrenocorticotropin-Responsive Gene Selective Alzheimer's Disease Indicator-1 in the Normal Adrenal Cortex and in Adrenocortical Adenomas and Carcinomas J. Clin. Endocrinol. Metab., March 1, 2004; 89(3): 1332 - 1339. [Abstract] [Full Text] [PDF]

				E. Lalli and P. Sassone-Corsi DAX-1, an Unusual Orphan Receptor at the Crossroads of Steroidogenic Function and Sexual Differentiation Mol. Endocrinol., August 1, 2003; 17(8): 1445 - 1453. [Abstract] [Full Text] [PDF]